These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
370 related items for PubMed ID: 15163507
1. Current status of live attenuated influenza virus vaccine in the US. Belshe RB. Virus Res; 2004 Jul; 103(1-2):177-85. PubMed ID: 15163507 [Abstract] [Full Text] [Related]
2. Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children. Belshe RB, Gruber WC. Philos Trans R Soc Lond B Biol Sci; 2001 Dec 29; 356(1416):1947-51. PubMed ID: 11779396 [Abstract] [Full Text] [Related]
3. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Ashkenazi S, Vertruyen A, Arístegui J, Esposito S, McKeith DD, Klemola T, Biolek J, Kühr J, Bujnowski T, Desgrandchamps D, Cheng SM, Skinner J, Gruber WC, Forrest BD, CAIV-T Study Group. Pediatr Infect Dis J; 2006 Oct 29; 25(10):870-9. PubMed ID: 17006279 [Abstract] [Full Text] [Related]
4. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, Bernstein DI, Hayden FG, Kotloff K, Zangwill K, Iacuzio D, Wolff M. N Engl J Med; 1998 May 14; 338(20):1405-12. PubMed ID: 9580647 [Abstract] [Full Text] [Related]
5. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine. Belshe R, Lee MS, Walker RE, Stoddard J, Mendelman PM. Expert Rev Vaccines; 2004 Dec 14; 3(6):643-54. PubMed ID: 15606348 [Abstract] [Full Text] [Related]
11. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Tam JS, Capeding MR, Lum LC, Chotpitayasunondh T, Jiang Z, Huang LM, Lee BW, Qian Y, Samakoses R, Lolekha S, Rajamohanan KP, Narayanan SN, Kirubakaran C, Rappaport R, Razmpour A, Gruber WC, Forrest BD, Pan-Asian CAIV-T Pediatric Efficacy Trial Network. Pediatr Infect Dis J; 2007 Jul 14; 26(7):619-28. PubMed ID: 17596805 [Abstract] [Full Text] [Related]
12. Duration of protection provided by live attenuated influenza vaccine in children. Ambrose CS, Yi T, Walker RE, Connor EM. Pediatr Infect Dis J; 2008 Aug 14; 27(8):744-8. PubMed ID: 18600188 [Abstract] [Full Text] [Related]
13. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials. Rhorer J, Ambrose CS, Dickinson S, Hamilton H, Oleka NA, Malinoski FJ, Wittes J. Vaccine; 2009 Feb 11; 27(7):1101-10. PubMed ID: 19095024 [Abstract] [Full Text] [Related]
15. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA. Pediatrics; 2006 Sep 11; 118(3):e570-8. PubMed ID: 16950948 [Abstract] [Full Text] [Related]
16. Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years. Belshe RB, Nichol KL, Black SB, Shinefield H, Cordova J, Walker R, Hessel C, Cho I, Mendelman PM. Clin Infect Dis; 2004 Oct 01; 39(7):920-7. PubMed ID: 15472840 [Abstract] [Full Text] [Related]